CD8A and neoplasm: Activated by T cell receptor (TCR) engagement with peptide antigens presented on major histocompatibility complex (MHC), CD8 T cell functions are modulated by co-stimulatory and co-inhibitory receptors to ensure balance between the immune reaction to foreign/tumor antigens and excessive auto-immune inflammatory response.1